Safety  	Safety  	 NNP	O
and  	and  	 CC	O
acceptability  	acceptability  	 NN	O
of  	of  	 IN	O
intrauterine  	intrauterine  	 JJ	B-NP
balloon  	balloon  	 NN	I-NP
stent  	stent  	 VBZ	I-NP
used  	used  	 VBN	O
in  	in  	 IN	O
uterine  	uterine  	 NN	O
after  	after  	 IN	O
hysteroscopic  	hysteroscopic  	 JJ	B-NP
adhesiolysis  	adhesiolysis  	 NN	I-NP
to  	to  	 TO	O
prevent  	prevent  	 VB	O
adhesion  	adhesion  	 JJ	B-NP
reformation  	reformation  	 NN	I-NP
To  	To  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
safety  	safety  	 NN	O
and  	and  	 CC	O
acceptability  	acceptability  	 NN	O
of  	of  	 IN	O
COOK  	COOK  	 NNP	O
intrauterine  	intrauterine  	 JJ	B-NP
balloon  	balloon  	 NN	I-NP
stent  	stent  	 NN	I-NP
in  	in  	 IN	O
uterine  	uterine  	 NN	O
for  	for  	 IN	O
one  	one  	 CD	O
week  	week  	 NN	B-NP
after  	after  	 IN	O
hysteroscopic  	hysteroscopic  	 JJ	B-NP
adhesiolysis 	adhesiolysis 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
79  	79  	 CD	O
females  	females  	 NNS	O
with  	with  	 IN	O
moderate-severe  	moderate-severe  	 NNP	B-NP
Asherman  	Asherman  	 NNP	I-NP
syndrome  	syndrome  	 NN	I-NP
undergoing  	undergoing  	 VBG	O
hysteroscopic  	hysteroscopic  	 JJ	B-NP
division  	division  	 NN	I-NP
of  	of  	 IN	I-NP
intrauterine  	intrauterine  	 JJ	I-NP
adhesion  	adhesion  	 NN	I-NP
were  	were  	 VBD	O
enrolled  	enrolled  	 VBN	O
from  	from  	 IN	O
June  	June  	 NNP	O
2012  	2012  	 CD	O
to  	to  	 TO	O
December  	December  	 NNP	O
2013 	2013 	 CD	O
.  	.  	 .	O
They  	They  	 PRP	O
were  	were  	 VBD	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
two  	two  	 CD	O
groups  	groups  	 NNS	O
of  	of  	 IN	O
intrauterine  	intrauterine  	 JJ	B-NP
balloon  	balloon  	 NN	I-NP
stent  	stent  	 NNS	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
51 	51 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
tailed  	tailed  	 JJ	O
intrauterine  	intrauterine  	 JJ	B-NP
contraceptive  	contraceptive  	 JJ	I-NP
device  	device  	 NN	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
28 	28 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
sterile  	sterile  	 JJ	O
swabs  	swabs  	 NN	O
were  	were  	 VBD	O
taken  	taken  	 VBN	O
from  	from  	 IN	O
cervical  	cervical  	 JJ	B-NP
canals  	canals  	 NNS	I-NP
for  	for  	 IN	I-NP
bacterial  	bacterial  	 JJ	I-NP
culture  	culture  	 NN	I-NP
by  	by  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
microbiologist 	microbiologist 	 NN	B-NP
.  	.  	 .	O
Each  	Each  	 DT	O
patient  	patient  	 NN	O
in  	in  	 IN	O
balloon  	balloon  	 NN	O
group  	group  	 NN	O
was  	was  	 VBD	O
requested  	requested  	 VBN	O
to  	to  	 TO	O
answer  	answer  	 VB	O
a  	a  	 DT	O
questionnaire  	questionnaire  	 NN	B-NP
survey  	survey  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
acceptability  	acceptability  	 NN	O
of  	of  	 IN	O
balloon  	balloon  	 NN	B-NP
stent.  	stent.  	 CD	I-NP
82.3 	82.3 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
them  	them  	 PRP	O
could  	could  	 MD	O
tolerate  	tolerate  	 VB	O
discomforts  	discomforts  	 VBN	O
during  	during  	 IN	O
balloon  	balloon  	 NN	O
placement  	placement  	 NN	O
and  	and  	 CC	O
86.3 	86.3 	 CD	O
%  	%  	 NN	O
desired  	desired  	 VBN	O
re-ballooning  	re-ballooning  	 JJ	O
if  	if  	 IN	O
necessary 	necessary 	 JJ	O
.  	.  	 .	O
Positive  	Positive  	 JJ	B-NP
microorganism  	microorganism  	 JJ	I-NP
cultures  	cultures  	 NNS	I-NP
were  	were  	 VBD	O
seen  	seen  	 VBN	O
in  	in  	 IN	O
17  	17  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
33.3 	33.3 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
balloon  	balloon  	 NN	O
group  	group  	 NN	O
versus  	versus  	 IN	O
8  	8  	 CD	O
( 	( 	 -LRB-	O
28.6 	28.6 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
intrauterine  	intrauterine  	 JJ	B-NP
contraceptive  	contraceptive  	 JJ	I-NP
device  	device  	 NN	I-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
And  	And  	 CC	O
the  	the  	 DT	O
positive  	positive  	 JJ	B-NP
rate  	rate  	 NN	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
different  	different  	 JJ	O
between  	between  	 IN	O
two  	two  	 CD	O
groups 	groups 	 NNS	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
relatively  	relatively  	 RB	O
safe  	safe  	 JJ	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
the  	the  	 DT	O
intrauterine  	intrauterine  	 JJ	B-NP
balloon  	balloon  	 NN	I-NP
stent  	stent  	 NN	I-NP
in  	in  	 IN	O
uterine  	uterine  	 NN	O
for  	for  	 IN	O
one  	one  	 CD	O
week 	week 	 NN	B-NP
.  	.  	 .	O
And  	And  	 CC	O
most  	most  	 JJS	O
patients  	patients  	 NNS	O
accept  	accept  	 VBP	O
readily  	readily  	 RB	O
the  	the  	 DT	O
intrauterine  	intrauterine  	 JJ	B-NP
balloon  	balloon  	 NN	I-NP
stent 	stent 	 NN	I-NP
.  	.  	 .	O
